Evicenter
Paxlovid (nirmatrelvir; ritonavir) in COVID-19
Manufacturer
Pfizer Inc
Prescribing information
Paxlovid (opens in a new tab)
Questions
41
Last updated

All questions

Guidelines: Paxlovid (nirmatrelvir; ritonavir) in COVID-19

1 question · 1 source

Guidelines

Paxlovid: which conditions raise the risk of severe COVID-19 (CDC list)?

“Age (50+ years) Age is the strongest risk factor for progressing to severe COVID-19.2 Vaccination status People who are unvaccinated or not up to date on their COVID-19 vaccinations are at an increased risk of severe COVID-19.2 Underlying medical conditions that increase the risk of severe COVID-19 include2: Diabetes Heart conditions Smoking, current or former Obesity Disabilities, including learning disabilities Certain racial and/or ethnic minority groups are at increased risk of severe outcomes due to inequities in healthcare and socioeconomic factors.2 Underlying medical conditions and factors associated with higher risk for severe COVID-192 Higher risk (conclusive evidence) Asthma Cancer Hematologic malignancies Cerebrovascular disease Chronic kidney disease* People receiving dialysis† Chronic lung diseases, limited to: Bronchiectasis COPD (chronic obstructive pulmonary disease) Interstitial lung disease Pulmonary embolism Pulmonary hypertension Chronic liver diseases, limited to: Cirrhosis Nonalcoholic fatty liver disease Alcoholic liver disease Autoimmune hepatitis Cystic fibrosis Diabetes mellitus type 1 Diabetes mellitus type 2* Disabilities, including Down syndrome Heart conditions (such as heart failure, coronary artery disease, or cardiomyopathies) HIV Mental health conditions, limited to: Mood disorders, including depression Schizophrenia spectrum disorders Neurologic conditions limited to dementia and Parkinson's disease Obesity (BMI ≥30 kg/m2 or ≥95th percentile in children) Physical inactivity Pregnancy and recent pregnancy Primary immunodeficiencies Smoking, current and former Solid organ or blood stem cell transplantation Tuberculosis Use of corticosteroids or other immunosuppressive medications Suggestive higher risk‡ Epilepsy Hemophilia Overweight (BMI ≥25 kg/m2, but <30 kg/m2) Sickle cell disease Substance use disorders Mixed evidence (inconclusive: no conclusions can be drawn from the evidence) Alpha-1 antitrypsin deficiency Bronchopulmonary dysplasia Hepatitis B and C Hypertension* Thalassemia” (opens the source at this quote in a new tab)

Note: This list is Centers for Disease Control and Prevention guidance as reproduced on the High-Risk Factors page of the Paxlovid HCP site, which cites the CDC page "Underlying conditions and the higher risk for severe COVID-19" as accessed March 6, 2026. The FAQ page of the same site prints the list without Parkinson's disease, epilepsy, and hemophilia. The EPIC-HR trial used its own risk-factor criteria.